MedPath

Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn

Completed
Conditions
Multi-drug Resistant Gram-negative Bacilli Colonization
Interventions
Other: MDR-GNB
Registration Number
NCT02653157
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

This is a prospective observational study to determine the role of colonization and identify the timing of development of drug resistance in multidrug resistant Gram-negative bacilli (MDR-GNB) causing infection among critically ill burn patients.

Detailed Description

This is a prospective observational study. Patients will be followed during a single admission for development of colonization or infection with MDR-GNB. Patient clinical characteristics, including infections, surgeries, and antibiotic exposure, will be collected in real-time.

Weekly surveillance wound and peri-rectal swabs and, if intubated, biweekly deep endotracheal or tracheostomy aspirates will be collected, de-identified, and stored from all patients and examined for the presence of MDR-GNB. All GNB isolates from blood, urine, respiratory, and wound cultures will be collected, coded, and stored.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  1. Severe burn injury, including partial or full thickness burn 20% or more total body surface area; or
  2. inhalation injury; or
  3. 18 years of age or older;
Exclusion Criteria
  1. Intensive care unit stay of less than 5 days;
  2. ICU admission more than 48 hours after burn trauma.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Burn patients with VAT or VAP with MDR-GNBMDR-GNBAdult patients with burn and/or inhalation injury requiring intubation
Primary Outcome Measures
NameTimeMethod
Time to MDR-GNB VAT/VAPFrom hospital admission until date of development of MDR-GNB VAT/VAP or date of death from any cause (assessed up to 52 weeks)
Species causing MDR-GNB colonizationFrom hospital admission through length of hospital stay, or date of death from any cause, whichever comes first (assessed up to 52 weeks)

Endotracheal tube or tracheostomy aspirates will be obtained upon admission and twice weekly; wound and perirectal area swabs will be collected weekly and will be used to characterize species.

Time to VAT/VAPTime of hospital admission until date of development of VAT/VAP or date of death from any cause (assessed up to 52 weeks)

defined by bacteria obtained from clinical bronchoscopy and patient symptoms as noted by chart review

Time to MDR-GNB colonizationFrom hospital admission until discharge from unit, or date of death from any cause (assessed up to 1 year)

surveillance samples for bacterial colonization will be collected weekly

Time to development of MDR and extreme drug resistant bacteriaFrom hospital admission until date of development of MDR or extremely drug resistant bacteria (assessed up to 52 weeks)

surveillance samples will be collected weekly

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of North Carolina Jaycee Burn Center

🇺🇸

Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath